Literature DB >> 11439378

Epidermal nerve fiber density in sensory ganglionopathies: clinical and neurophysiologic correlations.

G Lauria1, A Sghirlanzoni, R Lombardi, D Pareyson.   

Abstract

We assessed the involvement of somatic unmyelinated fibers in sensory ganglionopathies by skin biopsy and quantitative sensory testing (QST). Sixteen patients with ganglionopathy, 16 with axonal neuropathy, and 15 normal controls underwent skin biopsy at the proximal thigh and the distal leg. Intraepidermal nerve fibers (IENF) were immunostained by antiprotein gene product 9.5, and their linear density was quantified under light microscopy. Confocal microscopy studies with double staining of nerve fibers and basement membrane were also performed. Healthy subjects and neuropathy patients showed the typical proximodistal gradient of IENF density; in neuropathies, values were significantly lower at the distal site of the leg, confirming the length-dependent loss of cutaneous innervation. Conversely, ganglionopathy patients with hyperalgesic symptoms did not show any change of IENF density between the proximal thigh and the distal leg. The distinct pattern of epidermal denervation seen in sensory ganglionopathy reflected the degeneration of somatic unmyelinated fibers in a fashion that was not length-dependent, which was consistent with both clinical and neurophysiologic observations and supported the diagnosis. Copyright 2001 John Wiley & Sons, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11439378     DOI: 10.1002/mus.1107

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  16 in total

1.  Comparison of a simple method for quantitation of intraepidermal nerve fibres with a standard image analysis method using hypothenar skin.

Authors:  Einar P V Wilder-Smith; Adeline Chow
Journal:  J Neurol       Date:  2006-06-19       Impact factor: 4.849

2.  Longitudinal assessment of oxaliplatin-induced neuropathy.

Authors:  A Z Burakgazi; W Messersmith; D Vaidya; P Hauer; A Hoke; Michael Polydefkis
Journal:  Neurology       Date:  2011-08-24       Impact factor: 9.910

Review 3.  Advances in imaging technologies for the assessment of peripheral neuropathies in rheumatoid arthritis.

Authors:  Josefina Gutiérrez; Hugo Sandoval; Iván Pérez-Neri; Antonio Arauz; Juan Carlos López-Hernández; Carlos Pineda
Journal:  Rheumatol Int       Date:  2021-01-11       Impact factor: 2.631

Review 4.  Chemotherapy-induced peripheral neurotoxicity.

Authors:  Guido Cavaletti; Paola Marmiroli
Journal:  Nat Rev Neurol       Date:  2010-11-09       Impact factor: 42.937

5.  Non-length-dependent and length-dependent small-fiber neuropathies associated with tumor necrosis factor (TNF)-inhibitor therapy in patients with rheumatoid arthritis: expanding the spectrum of neurological disease associated with TNF-inhibitors.

Authors:  Julius Birnbaum; Clifton O Bingham
Journal:  Semin Arthritis Rheum       Date:  2013-10-30       Impact factor: 5.532

6.  Regression of diabetic complications by islet transplantation in the rat.

Authors:  A Remuzzi; R Cornolti; R Bianchi; M Figliuzzi; C Porretta-Serapiglia; N Oggioni; V Carozzi; L Crippa; F Avezza; F Fiordaliso; M Salio; G Lauria; R Lombardi; G Cavaletti
Journal:  Diabetologia       Date:  2009-09-30       Impact factor: 10.122

7.  Sensory neuronopathy involves the spinal cord and brachial plexus: a quantitative study employing multiple-echo data image combination (MEDIC) and turbo inversion recovery magnitude (TIRM).

Authors:  Yi-Fang Bao; Wei-Jun Tang; Dong-Qing Zhu; Yu-Xin Li; Chi-Shing Zee; Xiang-Jun Chen; Dao-Ying Geng
Journal:  Neuroradiology       Date:  2012-08-26       Impact factor: 2.804

8.  Erythropoietin both protects from and reverses experimental diabetic neuropathy.

Authors:  Roberto Bianchi; Belgin Buyukakilli; Michael Brines; Costanza Savino; Guido Cavaletti; Norberto Oggioni; Giuseppe Lauria; Monica Borgna; Raffaella Lombardi; Burak Cimen; Ulku Comelekoglu; Arzu Kanik; Cengiz Tataroglu; Anthony Cerami; Pietro Ghezzi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-12       Impact factor: 11.205

Review 9.  Immunotherapy Prospects for Painful Small-fiber Sensory Neuropathies and Ganglionopathies.

Authors:  Anne Louise Oaklander
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

10.  The pattern and diagnostic criteria of sensory neuronopathy: a case-control study.

Authors:  Jean-Philippe Camdessanché; Guillemette Jousserand; Karine Ferraud; Christophe Vial; Philippe Petiot; Jérôme Honnorat; Jean-Christophe Antoine
Journal:  Brain       Date:  2009-06-08       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.